The EU is buying up to 300 million doses of Pfizer's COVID-19 vaccine
- The European Commission said Wednesday it had struck a deal with Pfizer and BioNTech to buy up to 300 million doses of their COVID-19 vaccine.
- The 27 EU countries could buy 200 million doses, and have an option to purchase another 100 million.
- The move follows Pfizer's announcement on Monday that its experimental coronavirus vaccine, developed with BioNTech, was more than 90% effective against COVID-19.
- Visit Business Insider's homepage for more stories.
The European Commission said on Wednesday it had sealed a deal with Pfizer and BioNTech to buy up to 300 million doses of the companies' COVID-19 vaccine candidate.
The move follows Pfizer's announcement on Monday that its experimental vaccine developed with BioNTech was more than 90% effective, making them the first drugmakers to show successful interim data from a large-scale clinical trial of a coronavirus vaccine.
Under the EU deal, the 27 EU countries could buy 200 million doses, and have an option to purchase another 100 million.
The purchases could take place only after the vaccine is authorized as effective and safe by the EU drug regulator.
"I'm very happy to announce today's agreement with the European company BioNTech and Pfizer to purchase 300 million doses of the vaccine," the President of the European Commission Ursula von der Leyen said.
The EU has already signed supply deals with AstraZeneca, Sanofi and Johnson & Johnson for their experimental COVID-19 shots, and is talking with Moderna, CureVac and Novavax to secure their vaccines.
Do you have a personal experience with the coronavirus you’d like to share? Or a tip on how your town or community is handling the pandemic? Please email [email protected] and tell us your story.
Get the latest coronavirus business & economic impact analysis from Business Insider Intelligence on how COVID-19 is affecting industries.
Get the latest Pfizer stock price here.
Senior Care & Assisted Living Market
Medical Devices & Wearable Tech
AI in Healthcare
Remote Patient Monitoring
Source: Read Full Article